Back to FDA Applications sponsored by PHARMACIA AND UPJOHN

FDA Drug Application 020212 by PHARMACIA AND UPJOHN

Application Number020212
Application Type New Drug Application
Sponsor ApplicantPHARMACIA AND UPJOHN
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan CodeV


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP05/26/1995N       
AP05/8/2001SCM       
AP010/31/2002SLR4845004   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20212se7-004,005,006ltr.pdf 10/31/2002
AP010/31/2002SLR4846004   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20212se7-004,005,006lbl.pdf 10/31/2002
AP010/31/2002SLR4847005   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20212se7-004,005,006lbl.pdf 10/31/2002
AP010/31/2002SLR4848005   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20212se7-004,005,006ltr.pdf 10/31/2002
AP010/31/2002SE72069006   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20212se7-004,005,006ltr.pdf 10/31/2002
AP010/31/2002SE72070006   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20212se7-004,005,006lbl.pdf 10/31/2002
AP05/20/2005SLR11706008   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020212s008ltr.pdf 5/25/2005
AP05/20/2005SLR11714008   http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020212s008lbl.pdf 5/25/2005
AP07/3/2012SLR33088013   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020212s013ltr.pdf 7/9/2012
AP07/3/2012SLR33166013   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020212s013lbl.pdf 7/13/2012
AP04/11/2013SCM       
AP010/3/2013SCM       
AP04/18/2014SLR39105017   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020212Orig1s017ltr.pdf 4/21/2014
AP04/18/2014SLR39167017   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020212s017lbl.pdf 4/29/2014
AP01/6/2016SCM       




Back to FDA Applications sponsored by PHARMACIA AND UPJOHN